Valneva (Austria)

A second yearly booster dose of the VLA15 Lyme borreliosis vaccine candidate in healthy individuals

Human vaccines against Lyme borreliosis, the most common tick-borne illness in Northern Hemispheric temperate climates, remain unavailable. Previous evaluations demonstrated the safety and immunogenicity of primary and booster dosing with VLA15, an investigational vaccine contain...